BioMimetic Therapeutics Stock Price, News & Analysis (NASDAQ:BMTI)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About BioMimetic Therapeutics (NASDAQ:BMTI)

BioMimetic Therapeutics logoBioMimetic Therapeutics, Inc. is a biotechnology company engaged in developing and commercializing products to the healing of musculoskeletal injuries and diseases, including therapies for orthopedic, sports medicine and spine applications. The Company's Augment platform of product and product candidates include an engineered version of recombinant human platelet-derived growth factor BB (rhPDGF-BB), one of the wound healing and tissue repair stimulators in the body. Its platform regenerative technology for promoting tissue healing and regeneration combines rhPDGF-BB with tissue specific matrices, when appropriate. The matrices are engineered or natural scaffold materials, such as Beta Tri-Calcium Phosphate. The Company's product candidates include Augment Bone Graft (Augment), Augmen Injectable Bone Graft (Augment Injectable) and Augment Rotator Cuff Graft (Augment Rotator Cuff Graft). In March 2013, Wright Medical Group Inc completed acquisition of BioMimetic Therapeutics, Inc.

Receive BMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for BMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:BMTI
CUSIPN/A
Phone+1-615-8441280

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

BioMimetic Therapeutics (NASDAQ:BMTI) Frequently Asked Questions

What is BioMimetic Therapeutics' stock symbol?

BioMimetic Therapeutics trades on the NASDAQ under the ticker symbol "BMTI."

Who are some of BioMimetic Therapeutics' key competitors?

How do I buy BioMimetic Therapeutics stock?

Shares of BioMimetic Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact BioMimetic Therapeutics?

BioMimetic Therapeutics' mailing address is 389 Nichol Mill Lane, FRANKLIN, TN 37067, United States. The biotechnology company can be reached via phone at +1-615-8441280.


MarketBeat Community Rating for BioMimetic Therapeutics (BMTI)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  75
MarketBeat's community ratings are surveys of what our community members think about BioMimetic Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BioMimetic Therapeutics (NASDAQ:BMTI) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

BioMimetic Therapeutics (NASDAQ:BMTI) Earnings History and Estimates Chart

Earnings by Quarter for BioMimetic Therapeutics (NASDAQ:BMTI)

BioMimetic Therapeutics (NASDAQ BMTI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/5/2012Q312($0.23)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

BioMimetic Therapeutics (NASDAQ:BMTI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for BioMimetic Therapeutics (NASDAQ:BMTI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioMimetic Therapeutics (NASDAQ BMTI)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

BioMimetic Therapeutics (NASDAQ BMTI) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

BioMimetic Therapeutics (NASDAQ:BMTI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

BioMimetic Therapeutics (NASDAQ:BMTI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

BioMimetic Therapeutics (NASDAQ BMTI) Stock Chart for Sunday, December, 17, 2017

Loading chart…

This page was last updated on 12/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.